01
Repeating questions or information
Repeatedly forgetting recent events and asking the same question again within a short time.
Alzheimer's Disease, Dementia & Memory Changes
Alzheimer's Disease Diagnosis starts by understanding what has changed in memory and everyday function
Alzheimer's Disease is the most common cause of dementia, but it is not the same thing as every memory complaint and it is not an inevitable result of aging. A good evaluation combines the patient's history with family observations, cognitive assessment, neurological examination, laboratory testing and brain imaging, with specialized biomarkers used when they add clinically useful information.
Short answer:
if changes in memory or thinking begin to affect appointments, finances, medication, navigation, judgment or other daily tasks, early assessment is more useful than waiting for the problem to become severe.
01
Not a normal part of agingAge increases risk, but dementia is not an inevitable outcome of getting older
02
Alzheimer's Disease is progressiveBiological changes can begin before symptoms become obvious
03
Diagnosis is not based on one testClinical context and appropriate investigations are interpreted together
What is Alzheimer's Disease?
Alzheimer's Disease is a progressive neurological disease that affects memory, thinking and the ability to carry out everyday activities. It is the most common cause of dementia, while dementia itself is a syndrome that can result from several different diseases.
02
Difficulty managing familiar tasks
New problems with finances, medication, appointments or tools the person previously used confidently.
03
Getting lost in familiar places
Confusion about route, time or location beyond ordinary occasional forgetfulness.
04
Language or word-finding changes
New difficulty following conversation, naming objects or expressing thoughts accurately.
05
Changes in judgment and decision-making
Unusual decisions or clear new difficulty assessing situations or managing money.
06
Behavior or personality changes
Withdrawal, apathy, anxiety or other new behavioral changes can occur alongside cognitive decline.
Normal Aging, Mild Cognitive Impairment and Dementia
Typical age-related changes
A person may occasionally forget a name and remember it later, while remaining independent in everyday life.
Mild Cognitive Impairment MCI
Cognitive decline is greater than expected for age, but independence is largely preserved. Not every case of MCI is caused by Alzheimer's Disease and not every case progresses to dementia.
Dementia
Cognitive decline is sufficient to interfere with everyday function and independence. The next question is the underlying cause, which can include Alzheimer's Disease and other conditions.
Cognitive assessment is not an exam
How does Alzheimer's Disease assessment begin?
Assessment starts with the patient and someone who knows them well, because changes may be more visible at home than during a short clinic visit. Brief cognitive tools or more detailed neuropsychological assessment can then be used when appropriate, but scores are interpreted in context of education, language, hearing, vision and mental health.
- When did the problem begin, and has it progressed gradually or appeared quickly?
- What has changed in everyday independence and management of routine tasks?
- Could medication, depression, sleep problems or hearing loss be worsening cognition?
- Are there other neurological features that suggest a different cause of cognitive decline?
What is usually included in Alzheimer's Disease and dementia evaluation?
History & neurological examination
Symptoms, functional change, medications, mood and sleep together with an appropriate neurological exam.
Cognitive testing
Brief tools or more extensive neuropsychological assessment when the clinical picture is unclear.
Tests for alternative or treatable causes
Laboratory testing is selected according to the case, including nutritional, endocrine or other possible contributors.
Imaging & specialized biomarkers
MRI and, in selected patients, biomarker testing when it meaningfully improves diagnostic confidence or treatment decisions.
The role of brain imaging
Can MRI diagnose Alzheimer's Disease?
MRI is important in dementia evaluation because it can identify other causes of cognitive decline and may support assessment of the pattern of brain change, but it does not prove or exclude Alzheimer's Disease by itself. Imaging is interpreted together with history, examination and cognitive assessment.
- Look for previous strokes, vascular disease, tumors, hydrocephalus or other potentially relevant causes.
- Assess patterns of atrophy when this can help with dementia subtype assessment.
- EEG is not a routine test for Alzheimer's Disease itself, but may be requested for another question such as possible seizures.
Biomarkers — how diagnosis is changing
Blood, CSF and PET biomarkers are becoming more important — but they are not general screening tests
The 2024 Alzheimer's Association criteria gave a larger role to biomarkers of amyloid and tau, including CSF testing, PET imaging and high-performing blood-based biomarkers. In 2025, an evidence-based clinical practice guideline added practical recommendations for using selected blood-based biomarker tests in specialty care for people who already have objective cognitive impairment.
- Current guidance does not support routine clinical screening of symptom-free people for Alzheimer's pathology.
- A biomarker result should be interpreted in the clinical context rather than in isolation from symptoms and cognitive assessment.
- Availability, regulatory status, assay performance and intended use vary between health systems and individual tests.
How is Alzheimer's Disease treated today?
Treatment depends on disease stage, symptoms, other medical conditions, current medicines and the patient's and family's ability to follow the care plan.
Treatments that support symptoms and function
Medicines such as donepezil, rivastigmine or galantamine, and memantine in selected stages or situations, can be considered according to the individual patient's condition and tolerance.
- Do not stop memory medication or change its dose without medical review.
- Review other medicines because some can worsen cognitive burden or confusion.
- Sleep, hearing, mood and chronic medical conditions are part of the overall care plan.
Anti-amyloid treatment in early Alzheimer's Disease
In some health systems, anti-amyloid therapies such as lecanemab and donanemab are available for selected patients in early clinical stages after confirmation of amyloid pathology. These treatments do not restore memory to its previous level and are not suitable for everyone.
- Eligibility requires specialist assessment and confirmation of amyloid pathology.
- MRI monitoring is required because of Amyloid-Related Imaging Abnormalities (ARIA), including edema and microhemorrhage.
- Availability and regulatory approval differ between countries and health systems.
Family is part of the care plan
The family's role in everyday Alzheimer's care
As symptoms progress, support may be needed with medication, appointments, finances, driving, food and home safety. The goal is not to remove independence too early, but to add the level of support that is needed while preserving dignity and involving the patient in decisions whenever possible.
- Use a clear routine and consistent timing when possible.
- Watch for new changes in behavior, awareness or sleep rather than assuming every change is Alzheimer's progression.
- Caregiver health matters because long-term caregiving burden is real.
- Review driving, medication, fall and household safety as the disease stage changes.
The care plan changes with the disease
Alzheimer's Disease follow-up changes with stage and needs
Alzheimer's Disease changes over time, so follow-up should review cognition, independence, medication, sleep, mood, mobility, falls, nutrition, new behaviors and family needs.
- Early follow-up allows future planning before decisions become more difficult.
- Rapid deterioration over days or weeks should not automatically be attributed to Alzheimer's Disease; infection, medication effects or another acute problem may be responsible.
- The aim is to preserve function and quality of life as much as possible while adapting the plan to the current stage.
Do erectile dysfunction medicines such as sildenafil prevent Alzheimer's Disease?
No clinical recommendation supports using them to prevent Alzheimer's Disease. A 2024 observational Neurology cohort study in men with erectile dysfunction found an association between PDE5 inhibitor use and a lower rate of later Alzheimer's diagnosis, but observational association does not prove that the medicine caused the lower risk. Randomized trials would be needed before these drugs could be considered preventive therapy.
Neurological assessment of memory and dementia
Dr. Karim Ashraf
Consultant Neurologist, focusing on understanding the cause of cognitive change before selecting a test or medicine.
A good memory assessment does not start with the name of a disease. It starts with simpler questions: what changed, when did it change, and how has it affected the patient's life? The appropriate tools are then used to distinguish Alzheimer's Disease from other dementias or different causes of cognitive change.
Assessment: history from patient and family + neurological examination + cognitive assessment.
Investigations: selected when they answer a diagnostic question or can change management.
Follow-up: considers patient, family and everyday function — not a memory-test score alone.
Frequently Asked Questions About Alzheimer's Disease
Does every memory problem in an older adult mean Alzheimer's Disease?
No. Normal aging and many treatable or different medical conditions can affect memory. What matters is the pattern of change, how it progresses and whether it affects everyday function.
Is there one blood test that diagnoses Alzheimer's Disease?
Not as a stand-alone answer for every patient. Diagnosis combines history, cognitive assessment, examination and appropriate imaging or laboratory testing. In specialty care, selected blood-based biomarkers can now support the diagnostic workup when used according to validated performance criteria.
Does a normal MRI rule out Alzheimer's Disease?
No. MRI is useful for looking for other causes of cognitive decline and may support dementia subtype assessment, but a normal MRI does not exclude Alzheimer's Disease by itself.
Does EEG diagnose Alzheimer's Disease?
EEG is not a routine diagnostic test for Alzheimer's Disease. It may be requested for another clinical question, such as possible seizures or unusual episodes of altered awareness.
Is there a treatment that permanently stops Alzheimer's Disease?
No treatment restores the brain to its previous state or guarantees that progression will stop. Symptomatic treatments can help selected patients, and anti-amyloid therapies can slow decline in selected people with early Alzheimer's Disease who meet treatment criteria.
Can dementia risk be reduced?
Not every case can be prevented. Population-level evidence supports addressing vascular risk factors, physical activity, smoking, hearing loss, sleep and social and cognitive engagement as part of brain-health risk reduction.
When does memory or cognitive change need urgent assessment?
Rapid decline over days or weeks, loss of consciousness, new weakness, sudden speech difficulty or an acute change in behavior or awareness needs prompt assessment because this is not the usual slow pattern of Alzheimer's Disease.
Do erectile dysfunction medicines prevent Alzheimer's Disease?
No. Observational studies have reported associations that are scientifically interesting, but they do not prove prevention or justify using PDE5 inhibitors to prevent Alzheimer's Disease outside their approved medical indications.
If memory has changed, understand the cause before assuming Alzheimer's Disease
Book a memory assessment to review symptoms, previous reports and medication, then decide which investigations and next steps are appropriate for the patient and family.